Oxford Endovascular is an Oxford University spinout company commercialising OxiFlow, a novel blood flow diversion device (‘stent’) for treating Intracranial Aneurysms (ICAs).
Defined as a weakened point in a blood vessel, aneurysms occur where pulsing blood pressure causes the vessel wall to balloon. Untreated, ICAs can rupture causing bleeding into the brain which can lead to irreparable brain damage and death. OxiFlow is a tiny mesh tube created by laser-cutting a novel design from a tube of nickel titanium alloy. Fitting the natural shape of the blood vessel in the brain and inserted via a microcatheter, it diverts blood away from the ICA, allowing it to heal.